Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
出版年份 2019 全文链接
标题
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
作者
关键词
-
出版物
OncoImmunology
Volume -, Issue -, Pages 1-10
出版商
Informa UK Limited
发表日期
2019-01-18
DOI
10.1080/2162402x.2018.1560919
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human occupation of northern Australia by 65,000 years ago
- (2017) Chris Clarkson et al. NATURE
- Unknown
- (2017) Oncotarget
- Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy
- (2015) Kazutaka Masuko et al. IMMUNOLOGY LETTERS
- PTP1B inhibition suggests a therapeutic strategy for Rett syndrome
- (2015) Navasona Krishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- Twenty years of theMEROPSdatabase of proteolytic enzymes, their substrates and inhibitors
- (2015) Neil D. Rawlings et al. NUCLEIC ACIDS RESEARCH
- Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
- (2015) Kirsten Ridder et al. OncoImmunology
- Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
- (2014) Junya Ohtake et al. IMMUNOLOGY LETTERS
- Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen
- (2014) Hisashi Wada et al. JOURNAL OF IMMUNOTHERAPY
- In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes
- (2013) Estibaliz Alegre et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences
- (2013) Delphine Carbonnelle et al. PLoS One
- Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation
- (2013) Mathilde Bobinet et al. PLoS One
- Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
- (2012) M. Dosset et al. CLINICAL CANCER RESEARCH
- HLA Anchor Optimization of the Melan-A-HLA-A2 Epitope within a Long Peptide Is Required for Efficient Cross-Priming of Human Tumor-Reactive T Cells
- (2012) J.-M. Chauvin et al. JOURNAL OF IMMUNOLOGY
- MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
- (2012) Mathilde Bobinet et al. PLoS One
- Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation
- (2011) H. Ding et al. BLOOD
- CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
- (2011) Jianda Yuan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy
- (2010) Yann Godet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+and CD4+T Cells
- (2009) Hongwei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
- (2008) Yann Godet et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More